[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100490411":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":37,"locations":43,"responsibleParty":58,"collaborators":31,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":31,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":31,"enrollmentInfo":70,"targetDuration":31,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":31,"overallStatus":45,"whyStopped":31,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active treatment (Qingyan Lihou Decoction)","EXPERIMENTAL","It consists of 22 kinds of Chinese medicine as ingredients. It was prepared in granule form.",[13],"Drug: Qingyan Lihou Decoction",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","The placebo medication is composed of starch and an edible pigment and will be matched as closely as possible to the appearance and taste of Qingyan Lihou Decoction granules.",[19],"Other: Placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Qingyan Lihou Decoction","Chinese medicine granules",[9],[27],"Active treatment",{"type":6,"name":15,"description":29,"armGroupLabels":30,"otherNames":31},"Placebo granules",[15],null,[33],{"name":34,"affiliation":35,"role":36},"Zhixiu Lin","Hong Kong Institute of Integrative Medicine","PRINCIPAL_INVESTIGATOR",[38],{"name":39,"role":40,"phone":41,"phoneExt":31,"email":42},"Cho Wing Lo","CONTACT","35053476","louislo@cuhk.edu.hk",[44],{"facility":35,"status":45,"city":46,"state":31,"zip":31,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Hong Kong","HK",{"type":49,"coordinates":50},"Point",[51,52],114.17469,22.27832,{"lat":52,"lon":51},[55],{"name":56,"role":40,"phone":57,"phoneExt":31,"email":31},"Zhixiu LIN","28733252",{"type":36,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Prof. Lin Zhixiu","Professor","100490411","phase-2-chinese-medicine-for-treating-chronic-pharyngolaryngitis-100490411",false,"NCT05665777","Chinese Medicine for Treating Chronic Pharyngolaryngitis","The Effectiveness and Safety of Qingyan Lihou Decoction for the Treatment of Chronic Pharyngolaryngitis: A Randomized, Double-blinded, Placebo-controlled Trial","Inclusion Criteria:\n\n* 18 years of age or above (Chinese subjects only);\n* Persistent symptoms of pharyngitis (sore throat, globus, dry throat, dry cough, throat irritation) for more than 3 weeks;\n* Determined to be the following Chinese medicine syndromes by Registered Chinese Medicine Practitioners (RCMPs): Wind-heat invading the upper-jiao, or phlegm heat or Yin deficiency;\n* Visual analog scale (VAS) score for pain ≥ 50 mm;\n* Numeric rating scale (NRS) ≥ 6; and\n* Be able to give voluntary written informed consent.\n\nExclusion Criteria:\n\n* Known severe medical conditions, such as cardiovascular, liver or renal dysfunction, diabetes mellitus, cancers, cerebrovascular diseases, blood system diseases;\n* Concomitant use of steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, and immunotherapy within the past week;\n* Impaired hematological profile and liver \u002F renal function exceed the upper limit of the reference value by 2 times;\n* Known Allergic rhinitis;\n* Known Gastroesophageal Reflux Disease (GERD);\n* Known cancer or suspected cancer of throat\u002Foesophagus;\n* Mechanical obstruction of the throat accountable for the symptoms;\n* Known alcohol and\u002For drug abuse;\n* Known allergic history to any Chinese herbal medicines; and\n* Subjects who are known pregnant or lactating.","ALL","18 Years",{"count":71,"type":72},74,"ESTIMATED","INTERVENTIONAL",[75],"PHASE2","A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine formula in treating Chronic pharyngolaryngitis. Subjects will be randomized into a treatment group or placebo group for 8 weeks, and then followed by an 8-week post-treatment visit.",[78],"Chronic Pharyngolaryngitis (Disorder)","2026-07-28",{"date":81,"type":82},"2026-07-30","ACTUAL",{"date":84,"type":82},"2023-03-30",{"date":86,"type":72},"2027-07-31",{"name":5,"class":6},1]